MYGN 28.6 (+2.51%)
US62855J1043• Medical Diagnostics & Research• Diagnostics & Research
Intro Stories Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. MYGN

Myriad Genetics (MYGN) Competitor Comparison

We are evaluating the key criteria listed to compare Myriad Genetics (MYGN) against its competitors in the Diagnostics & Research industry.

Market Capitalization

28 / 58

Gross Profits

22 / 52

Total Revenue

25 / 57

EBITDA

51 / 56

Free Cashflow

42 / 56

Quick Ratio

44 / 57

Earnings per Share

44 / 57

Dividend yield

0 / 8

Total Cash

36 / 57

Performance 3 years

17 / 58

Performance 5 years

28 / 58

Performance 10 years

32 / 58

Linearity 3 years

16 / 58

Linearity 5 years

4 / 58

Linearity 10 years

9 / 58

Total Rank

23 / 58

Dividend Rank

22 / 58

Valuation Rank

28 / 58

Piotroski Rank

50 / 58

Muliplier Rank

56 / 58

Performance 5 years - MYGN ranking 28 / 58

These are the competitors of Myriad Genetics in the industry Diagnostics & Research ranked by performance 5 years
1. RadNet RDNT
350.73
2. Lantheus Holdings LNTH
336.16
3. Medpace Holdings MEDP
328.29
4. Natera NTRA
282.55
5. Danaher DHR
118.79
6. Meridian Bioscience VIVO
118.46
7. Thermo Fisher Scientific TMO
107.82
8. Icon ICLR
101.33
9. Fulgent Genetics FLGT
97.09
10. Mettler-Toledo MTD
94.17
11. DexCom DXCM
90.96
12. IDEXX Laboratories IDXX
84.98
13. Agilent Technologies A
76.97
14. Twist Bioscience TWST
61.56
15. DarioHealth DRIO
61.4
16. IQVIA Holdings IQV
59.43
17. Charles River Laboratories CRL
50.28
18. Laboratory Corp of America Holdings LH
48.85
19. PerkinElmer PKI
48.44
20. Quest Diagnostics DGX
46.57
21. Waters WAT
40.49
22. Qiagen QGEN
37.24
23. CareDx CDNA
31.95
24. Trinity Biotech TRIB
31.15
25. Co-Diagnostics CODX
24.76
26. Ortho Clinical Diagnostics Holdings OCDX
13.74
27. Heska HSKA
12.14
28. Myriad Genetics MYGN
-1.08
29. Anixa Biosciences ANIX
-16.04
30. Syneos Health SYNH
-16.98
31. Bioventus BVS
-26.03
32. Olink Holding OLK
-26.82
33. NeoGenomics NEO
-27.37
34. Sotera Health SHC
-37.78
35. Exact Sciences EXAS
-39.26
36. Sera Prognostics SERA
-48.97
37. Illumina ILMN
-55.42
38. Inotiv NOTV
-57.26
39. Neogen NEOG
-58.53
40. National Research NRC
-64.63
41. Guardant Health GH
-65.4
42. Personalis PSNL
-66.63
43. Pacific Biosciences of California PACB
-67.33
44. Enzo Biochem ENZ
-68.91
45. Psychemedics PMD
-72.06
46. MaxCyte MXCT
-76.28
47. MDxHealth MDXH
-78.44
48. bioAffinity Technologies BIAF
-79.29
49. Interpace Biosciences IDXG
-81.1
50. Exagen XGN
-82.38
51. Global Cord Blood CO
-86.47
52. Biodesix BDSX
-86.98
53. Precipio PRPO
-87.61
54. Neuronetics STIM
-92.42
55. Aspira Womens Health AWH
-92.98
56. Organovo Holdings ONVO
-95.1
57. SeqLL SQL
-95.22
58. Prenetics Global PRE
-96.24
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.